UNSPSC 51286708: Vaneprim

This classification denotes an antibiotic with the molecular formula C23H28N4O8S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M3EKF65MHG, chemically known as ( -)-alpha-(4-amino-5-(3,4,5-trimethoxybenzyl)-2-pyrimidinylamino)-3-ethoxy-4-hydroxy-alpha-toluenesulfonsaeure but more generally known as vaneprim, which bears US NIH Compound Identifier 216266. European Medicines Agency schedules Vaneprim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00021MIG.

The term VANEPRIM is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 37, No. 6, 1983, List 23). VANEPRIM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

UNSPSC 51286708 Vaneprim is a Commodity code under which state and local governments procure pharmaceutical products, medical supplies, and related health-care consumables for emergency response, public health, and pharmacy benefit programs. Recent solicitations show demand for naloxone and drug deactivation systems, emergency medical supplies for fire-rescue divisions, generic pharmaceuticals distributed through wholesalers, and direct-to-manufacturer prescription programs. The issuing bodies span county health departments, municipal fire services, state health and human services agencies, and multistate cooperative purchasing alliances. The work involves competitive procurement of finished pharmaceutical products and medical supplies with specified packaging, expiration-date requirements, National Drug Codes, and delivery timelines to public facilities.

Recent activity centers in Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response deadline, requiring quarterly deliveries and vendor responsibility for shipping. The City of Tampa's Purchasing Department posted IFB 26P00145 on March 25, 2026 for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000.00 and a March 13, 2026 response deadline, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 on January 20, 2026 with a March 26, 2026 deadline for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local government facilities, including Oregon. Texas Health and Human Services Commission issued an exploratory RFI (HHS0017013) on April 3, 2026 regarding direct-to-manufacturer prescription programs, seeking vendor capabilities for implementing Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions outside traditional pharmacy benefit manager arrangements.